A systematic review of the use of atypical antipsychotics in autism

Journal of Psychopharmacology

Volumn 16, Issue 1, 2002, Pages 93-101

  Barnard, L ^a   Young, A H ^b   Pearson, J ^a   Geddes, J ^c   O'Brien, G ^d  

^a Developmental Psychiatry Research Unit   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

Atypical antipsychotics; Autistic disorder; Learning disability; Review; Risperidone

Indexed keywords

AMISULPRIDE; BENZAMIDE DERIVATIVE; BENZATROPINE; CLONAZEPAM; CLOZAPINE; ILOPERIDONE; NEUROLEPTIC AGENT; OLANZAPINE; PIPAMPERONE; PLACEBO; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE; ZOTEPINE;

ADOLESCENT; ADULT; AKATHISIA; AUTISM; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVELOPMENTAL DISORDER; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; HYPERACTIVITY; LANGUAGE; MAJOR CLINICAL STUDY; MOOD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TACHYCARDIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; AUTISTIC DISORDER; BEHAVIOR; CLINICAL TRIALS; COGNITION; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 0036208307     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600113     Document Type: Review

References (50)

1. Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms
2. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
3. A comparison of haloperidol and behavior therapy and their interaction in autistic children
4. Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study
5. Antipsychotics in children and adolescents
6. Behavioural effects of haloperidol in young autistic children
7. Risperidone for aggression and self-injurious behavior in adults with mental retardation
8. Brief report: Two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism
9. Amisulpride versus bromocriptine in infantile autism: A controlled crossover comparative study of two drugs with opposite effects on dopaminergic function
10. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
11. Pimozide in autistic children
12. An open clinical trial of risperidone monotherapy in young children with autistic disorder
13. The antipsychotics: A pediatric perspective
14. Use of risperidone in pervasive developmental disorders: A case series
15. Risperidone in PDD
16. A scale for rating symptoms of patients with the syndrome of autism in real life settings
17. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
18. The Yale-Brown Obsessive Compulsive Scale I: Development, use and reliability
19. Risperidone treatment of children and adolescents with developmental disorders
20. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?
21. Risperidone and explosive aggressive autism
22. Olanzapine in PDD
23. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
24. Olanzapine for autistic disorder with hyperactivity
25. Open-label quetiapine in the treatment of children and adolescents with autistic disorder
26. Psychopharmacology
27. Risperidone in adults with autism or pervasive developmental disorder
28. Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study
29. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders
30. A multi-centre double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design
31. An open trial of risperidone in young autistic children
32. Measuring behaviour in developmental disability: A review of existing schedules
33. Executive functions and developmental psychopathology
34. Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration
35. Risperidone in children and adolescents with pervasive developmental disorder: Pilot trial and follow-up
36. Risperidone in the treatment of two very young children with autism
37. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
38. Risperidone in the treatment of pervasive developmental disorder
39. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
40. Clinical effect of buspirone in autistic children
41. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania
42. Risperidone and mania
43. Psychopharmacology in autism
44. Atypical antipsychotic agents: A critical review
45. Clinical effects of clozapine on autistic disorder